ATS Assemblies & Sections

An in-depth exploration of the evolving understanding of inflammation in COPD, focusing on the differences between type 1/3 and type 2 inflammatory pathways and their clinical relevance. Experts will discuss current gaps in COPD management and the potential of precision medicine to improve outcomes for patients with persistent symptoms or frequent exacerbations. The program will also review recent clinical trial data on type 2 biologics, strategies for identifying appropriate candidates through biomarkers and comorbidities, and key areas for future research, including long-term outcomes, treatment tapering, and therapy optimization.

* Produced by the AII Assembly

Host:
• Sara Assaf, MD - Assistant Professor, Division of Pulmonary, Critical Care and Sleep at the University of New Mexico
Guests
• Nick Hanania, MD, MS - Director, Airways Clinical Research Center, Brown Foundation, Professor of Medicine, Baylor College of Medicine
• Stephanie Christenson, MD MAS - Associate Professor, Division of Pulmonary, Critical Care, Allergy, & Sleep, UCSF
• Surya P Bhatt MD, MSPH - Professor of Medicine, Endowed Professor of Airways Disease, University of Alabama at Birmingham
• Klaus Rabe, MD, PhD, FERS - Professor of Pulmonary Medicine, University of Kiel

🔹 00:00:00 | Introduction (0–4 min)
🔹 00:04:04 | Setting the Stage: Why Type 2 Inflammation Matters in COPD
🔹 00:08:07 | The Science Behind COPD and Type 2 Pathways
🔹 00:12:08 | How Inflammation Shapes Disease Progression
🔹 00:16:11 | Current and Emerging Treatments for COPD
🔹 00:24:20 | Biomarkers and Precision Medicine
🔹 00:32:25 | New Frontiers and Ongoing Research
🔹 00:52:41 | Wrapping Up and Key Takeaways

Field walking tests are common outcome measures used in pulmonary rehabilitation to measure an individual's exercise capacity. With a growing number of other outcome measures that also assess exercise capacity, should people still continue to use field walking tests? This podcast aims to highlight why field walking tests should still be used and the common pitfalls when executing these tests.

00:00 – Introduction
02:10 – Why Field Walking Tests Matter
06:25 – The Big Three Tests
12:40 – Choosing the Right Test
13:20 – Limitations of Current Field Tests
13:35 – Emerging Role of Step Tests
15:05 – Three Key Takeaways (Dr. Machado)
16:45 – Closing Remarks
17:30 – Outro

**Produced by the PR Assembly

The intersection of pulmonary and palliative medicine is particularly relevant in the care of patients with interstitial lung disease (ILD). The complex medical, psychological, and physical needs of this population necessitate a collaborative approach, integrating the expertise of both specialties. Approaching care with curiosity rather than judgment fosters interdisciplinary partnership, leading to more comprehensive, patient-centered strategies that enhance outcomes for ILD patients and their caregivers across all dimensions of care.

#PulmonaryPalliativeCare
#AdvancedLungDisease
#InterstitialLungDisease
#Partnerships #Collaboration
#PalliativeMedicine #ATS #AAHPM #WESCOEfoundation #AdvancedIllnessPlanning #GoalsOfCare #TeamBasedCare #WholePersonCare #BeCuriousNotJudgmental

*Produced by the BSHSR Assembly